Identification of a Potential Peptide Inhibitor of SARS-CoV-2 Targeting its Entry into the Host Cells

ConclusionOur findings suggest that computationally developed inhibitory peptide may be developed as an anti-SARS-CoV-2 agent for the treatment of SARS-CoV-2 infection. We further plan to pursue the peptide in cell-based assays and eventually for clinical trials.

http://link.springer.com/10.1007/s40268-020-00312-5

Source: Drugs in R&D - June 25, 2020 Category: Drugs & Pharmacology Source Type: research